Clinical Trials
Prostate Cancer Recurrence After Treatment with Surgery or Radiation

This Information is provided to help patients identify clinical trials for educational purposes and not to recruit patients for any specific trials. Patients should consult with their personal doctor and the trial sponsors for additional information on trials of interest.

Study of Radiation Therapy Plus Enzalutamide Post Prostatectomy on Patient Outcomes

Number: NCT02203695
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Astellas Pharma Inc|Medivation, Inc.
Sponsor Trial Information
Trial Location(s) and Contact(s)
Study of Immunotherapy in Patients With Biochemically Recurrent Prostate Cancer

Number: NCT02649439
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC)
Sponsor Trial Information
Trial Location(s) and Contact(s)
Study of Olaparib in Men With High-Risk Recurrent Prostate Cancer Following Prostate Surgery

Number: NCT03047135
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sponsor Trial Information
Trial Location(s) and Contact(s)
Study of Radiation and Androgen Deprivation therapy +/- Abiraterone and Apalutamide for Rising PSA after Prostate Surgery

Number: NCT03141671
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Dana-Farber Cancer Institute|Janssen Pharmaceutica
Sponsor Trial Information
Trial Location(s) and Contact(s)
A Trial of Androgen Deprivation Therapy and Apalutamide With Radiation Therapy Followed by Docetaxel in Men With Recurrent Prostate Cancer After Prostate Surgery (STARTAR)

Number: NCT03311555
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Tian Zhang, MD|Duke University
Sponsor Trial Information
Trial Location(s) and Contact(s)
BEACON: Brachytherapy, Radiation and Androgen Deprivation Therapy for the Treatment of Recurrence of Prostate Cancer After Radiation Therapy

Number: NCT03553602
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Loyola University
Sponsor Trial Information
Trial Location(s) and Contact(s)




PHEN,Inc. © 2018 All rights reserved